Thomas Ross Email & Phone Number

Los Gatos, California, United States

➪ Worked with 𝟴+ 𝗰𝗹𝗶𝗲𝗻𝘁𝘀 𝘁𝗼 𝗹𝗲𝗮𝗱 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗿𝗮𝗶𝘀𝗶𝗻𝗴 efforts toward successful launches, clinical studies, construction of clinical advisory teams and promotional materials. ➪ 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 & 𝗳𝗼𝗿𝗺𝗲𝗿 𝗰𝗹𝗶𝗲𝗻𝘁𝘀: Nfocus Neuromedical, Medical University of Texas, OptiScan, PONTiS Orthopaedics, Endophys, SpineSelect, BioCardia, Bay Materials, and others…Professional consulting impact:➪ 𝗟𝗮𝗻𝗱𝗲𝗱 $𝟭.𝟱𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗻𝗲𝘄 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 for orthopedic surgery product developer. ➪ 𝟯 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝗮𝗰𝗾𝘂𝗶𝘀𝗶𝘁𝗶𝗼𝗻𝘀➪ Successful product launches with promotional & marketing material support.➪ 𝗢𝗻-𝘀𝗶𝘁𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, including national and international travel, for critical care monitoring developer.

I collaborate with founders worldwide, helping them build their startup, by utilizing my 30+ years of experience in the medical device space.

Fremont, Ca

➪ Led funding efforts, resulting in successful acquisition by Straumann Group (Q4 2019). ➪ Drove 10x growth in Bay Materials revenue. ➪ Bay Materials/ZenduraDental remains a lead material developer for orthodontics.

San Francisco Bay Area

➪ Developed fundraising materials and led critical round providing resources to expand the full-time team of this orthopaedic/tendon repair surgery products company. ➪ Provided leadership for R&D, sales, marketing, quality management and regulatory functions.

San Carlos, Ca

➪ Worked with 𝟴+ 𝗰𝗹𝗶𝗲𝗻𝘁𝘀 𝘁𝗼 𝗹𝗲𝗮𝗱 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗳𝘂𝗻𝗱𝗿𝗮𝗶𝘀𝗶𝗻𝗴 efforts toward successful launches, clinical studies, construction of clinical advisory teams and promotional materials. ➪ 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 & 𝗳𝗼𝗿𝗺𝗲𝗿 𝗰𝗹𝗶𝗲𝗻𝘁𝘀: Nfocus Neuromedical, Medical University of Texas, OptiScan, PONTiS Orthopaedics, Endophys, SpineSelect, BioCardia, Bay Materials, and others…Professional consulting impact:➪ 𝗟𝗮𝗻𝗱𝗲𝗱 $𝟭.𝟱𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗶𝗻 𝗻𝗲𝘄 𝗳𝘂𝗻𝗱𝗶𝗻𝗴 for orthopedic surgery product developer. ➪ Successful product launches with promotional & marketing material support.➪ 𝗢𝗻-𝘀𝗶𝘁𝗲 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝘆 𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, including national and international travel, for critical care monitoring developer.

Palo Alto, Ca

➪ One of two co-founders/principals successful in raising $16 million in new capital from two top venture funds.➪ Principal company representative to worldwide physician/investigator community, including setting up 10 investigator sites in Germany for small-vessel stent-graft clinical study.➪ Initiated study centers in Denmark, Latvia, Slovenia, Holland, for intra-aneurysmal device study.

➪ I founded Acta Vascular to acquire and market the Goldvalve Balloon and other neurovascular products from MinVasys Inc. of Paris.➪ Raised $1 million in funding; completed product acquisition and tech-transfer; maintained sales base of $2 million/yr through WW network of distributors. ➪ Acta was merged into Nfocus in early 2007 at an increased valuation of $3.5 million.

➪ Directed all sales, customer service and marketing activities through a hybrid direct/distributor organization. Developed international distribution network.➪ Built a team to develop innovative tools to aid marketing of physician practices. ➪ Continued sales growth to $9 million. Parallax was acquired by ArthroCare (now Smith&Nephew) in late 2003.

➪ Directed a 15-member department including Marketing Communications, Product Management & Customer Service➪ Grew sales & share to $50million➪ Initiated international distribution and drove Oratec’s first device acquisition.➪ Oratec was acquired by the Smith & Nephew in 2002.

➪ Acquired this manufacturing shop to pivot to new medical device customers and new production machinery.➪ Increased business volume by 5x➪ Sold the business to return to the medical device market

➪ Grew revenue from $0 to $10 million➪ Built domestic salesforce of 12 and recruited, trained and managed a network of international distributors covering 20 countries. ➪ Acquired by Medtronic in 1995. ➪ Developed effective product management and customer service functions.

➪ Recruited and trained 25 domestic distributors for orthopedic product launch.➪ Instrumental in series D private equity funding of $13 million➪ Successful launch of first commercial product.

➪ Created direct salesforce from 0 to a team of over 50 reps, including territory definition, compensation plans & performance goals.➪ Launched new spinal fusion treatment system➪ Grew sales from $7million to over $32million➪ Officer-level duties included key investor presentations for successful $20 million secondary stock offering

Mba, Finance, Marketing

Mt(Ascp), Licensed Medical Technologist

Msph, Epidemiology

Ba, Biology